BIOMEDICAL RES GROUP INC has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Norway. Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are SOMA GEN-ICHIRO, SOMA GENICHIRO and BIOGHURT BIOGARDE GMBH & CO KG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Norway | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | Hong Kong | 1 | |
#11 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Organic fine chemistry | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Foods | |
#4 | Microorganisms | |
#5 | Fermentation | |
#6 | Special foods | |
#7 | Specific use of cosmetics | |
#8 | Fodder | |
#9 | Peptides | |
#10 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Soma Gen-Ichiro | 15 |
#2 | Inagawa Hiroyuki | 14 |
#3 | Kohchi Chie | 14 |
#4 | Nishizawa Takashi | 11 |
#5 | Takahashi Yukinori | 4 |
#6 | Gen-Ichiro Soma | 2 |
#7 | Hiroyuki Inagawa | 2 |
#8 | Chie Kohchi | 2 |
#9 | Takashi Nishizawa | 1 |
#10 | Yutaro Kobayashi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021060127A1 | Lipopolysaccharide production method | |
WO2021039554A1 | Cancer chemotherapy supporting agent, food, and drug | |
BR112019024953A2 | AGENT, FOOD OR MEDICINE TO IMPROVE CEREBRAL FUNCTION | |
WO2007102442A1 | Monoclonal antibody, hybridoma, and method for quantification of lipopolysaccharide | |
EP2042520A1 | Method for production of limulus-positive glycolipid, limulus-positive glycolipid, and limulus-positive glycolipid blend |